Spots on the liver, known clinically as focal liver lesions, have dozens of possible causes ranging from completely harmless growths to infections to cancer. The majority turn out to be benign, discovered by accident when imaging is done for an unrelated reason. These incidental findings are so common in daily radiology practice that they sometimes lead to unnecessary follow-up testing, which is itself a recognized problem in medicine.1PubMed Central. WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver Understanding the range of causes helps put a finding like this in perspective.
Hemangiomas, the Most Common Benign Liver Spot
If you are told you have a spot on your liver and you are otherwise healthy, there is a good chance it is a hemangioma. These are the single most common benign liver tumor, typically found incidentally during an ultrasound or CT scan ordered for something else entirely.2PubMed Central. Hepatic hemangioma: What internists need to know A hemangioma is essentially a tangle of blood vessels that forms a mass within the liver tissue. It arises from a vascular malformation, though the exact reason some people develop them and others do not remains unclear.
Most hemangiomas are small, cause no symptoms, and never need treatment. They do not become cancerous. They can usually be identified on imaging alone, without a biopsy, because they have a characteristic pattern on contrast-enhanced scans: they fill in slowly from the edges with contrast material, giving radiologists a reliable visual signature. The main practical concern is that a very large hemangioma, particularly one over about 10 centimeters, can occasionally cause abdominal pain or, rarely, bleed. But most people with a hemangioma will never know it is there unless imaging happens to catch it.
Focal Nodular Hyperplasia
The second most common benign liver tumor is focal nodular hyperplasia (FNH), which accounts for roughly 3% to 5% of all primary liver tumors.3JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. Focal Nodular Hyperplasia of the Liver without a Central Scar: A Rare Case Report FNH occurs most often in women during their middle years. Rather than being a true tumor in the way most people think of that word, FNH appears to be the liver’s overgrowth response to an abnormal artery. Research has shown that the lesion is fed by an unusually large artery that branches into a spider-like structure, and the surrounding liver tissue proliferates in reaction to the altered blood flow.4PubMed. On the pathogenesis of focal nodular hyperplasia of the liver
On imaging, FNH classically shows a central scar, a fibrous star-shaped mark in the middle of the lesion that helps radiologists identify it. However, that hallmark is not always present, and FNH without a central scar can be harder to diagnose, sometimes requiring additional MRI sequences or follow-up imaging to distinguish it from something more concerning.3JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. Focal Nodular Hyperplasia of the Liver without a Central Scar: A Rare Case Report Like hemangiomas, FNH does not become cancerous, and most cases require no treatment at all.
Hepatocellular Adenomas
Hepatocellular adenomas (HCAs) are rarer benign tumors that occur mainly in women taking oral contraceptives.5PubMed. Subtype classification of hepatocellular adenoma Unlike hemangiomas and FNH, adenomas carry real risks. They bleed frequently and, in a small subset, can transform into liver cancer. This is what separates HCAs from the more common benign spots: they sometimes demand action.
Research into the genetics of HCAs has revealed several distinct subtypes, each with different behavior. The most common subtype, inflammatory HCA, makes up about half of all cases and occurs more frequently in people with a higher body mass index. A smaller but clinically important subtype involves mutations in the beta-catenin pathway, accounting for roughly 10% to 15% of cases. These beta-catenin-mutated adenomas carry the greatest risk of turning malignant and can be difficult to distinguish from early liver cancer on biopsy.5PubMed. Subtype classification of hepatocellular adenoma Because of these risks, the management of HCAs is more aggressive than for other benign liver spots: stopping hormonal contraception, monitoring the lesion closely, and in some cases surgically removing it.
Simple Cysts
Liver cysts are fluid-filled sacs that affect an estimated 5% to 10% of the population.6PubMed Central. Complications arising in simple and polycystic liver cysts On an ultrasound, they appear as dark, round spots with thin walls and no internal complexity. A simple liver cyst is one of the most reassuring findings in radiology. It has no cancer potential. Most people with them never develop symptoms. Only about 5% of patients with liver cysts eventually need any intervention, and that is usually because a cyst has grown large enough to press on surrounding structures and cause discomfort.6PubMed Central. Complications arising in simple and polycystic liver cysts
The picture gets more complicated when cysts are numerous. In polycystic liver disease, which is often inherited alongside polycystic kidney disease, the liver may contain dozens or even hundreds of cysts. In those cases, the sheer volume of cysts can enlarge the liver and cause symptoms like abdominal fullness, pain, or shortness of breath. But even polycystic liver disease is not a cancer risk. The concern is mechanical, not malignant.
Fatty Deposits That Mimic Tumors
Not every spot on the liver is actually a growth or a cyst. In people with fatty liver disease, fat does not always distribute evenly across the organ. Patches of focal fatty infiltration, areas where fat has accumulated more densely, can look like solid masses on ultrasound or CT. The reverse also occurs: in a liver that is diffusely fatty, small islands of normal liver tissue (focal fatty sparing) stand out as apparently different spots.7PubMed Central. Fatty liver deposition and sparing: a pictorial review Both patterns can be confused with liver metastases or other tumors on initial imaging.8South African Journal of Radiology. Focal fatty infiltration and focal fatty sparing of the liver
In one published case, multifocal nodular fatty sparing was initially suspected to be metastatic disease or a primary multifocal tumor before additional imaging clarified the diagnosis.9PubMed Central. Multifocal Nodular Fatty Sparing Mimicking Hepatic Tumors MRI is particularly helpful in resolving this kind of confusion, because fat behaves in a predictable way on certain MRI sequences. When a lesion loses signal on “out-of-phase” images compared to “in-phase” images, the radiologist can confidently call it fat rather than a worrying mass.7PubMed Central. Fatty liver deposition and sparing: a pictorial review This is worth knowing because fatty liver is extremely common, and these pseudo-lesions generate a lot of unnecessary anxiety.
Liver Abscesses
When bacteria or parasites infect the liver, they can form abscesses: walled-off collections of pus that show up as spots on imaging. There are two main types. Pyogenic (bacterial) liver abscesses are typically caused by common gut bacteria. In one study from a tertiary center, the most frequent culprits were Escherichia coli and Enterobacter cloacae.10PubMed Central. Profile of Amoebic vs Pyogenic Liver Abscess and Comparison of Demographical, Clinical, and Laboratory Profiles of these Patients From a Tertiary Care Center in Northern India Pyogenic abscesses often arise in the setting of biliary disease, recent abdominal surgery, or diabetes.
Amoebic liver abscesses, caused by the parasite Entamoeba histolytica, tend to present differently. They are often solitary, located in the right lobe, and historically associated with alcohol use.10PubMed Central. Profile of Amoebic vs Pyogenic Liver Abscess and Comparison of Demographical, Clinical, and Laboratory Profiles of these Patients From a Tertiary Care Center in Northern India Blood tests for antibodies against the amoeba are helpful in diagnosis. Historically, pyogenic abscesses have carried a worse prognosis than amoebic ones, though outcomes depend heavily on how quickly the abscess is identified and treated. Needle aspiration, draining the abscess through a needle guided by imaging, is a key tool both for diagnosis and for treatment.
Parasitic Cysts
In many parts of the world, a spot on the liver may turn out to be a parasitic cyst caused by Echinococcus granulosus, the tapeworm responsible for cystic echinococcosis (also called hydatid disease). The liver is the most common organ affected by this parasite.11PubMed Central. Cystic echinococcosis of the liver: A primer for hepatologists Hydatid cysts develop slowly and can grow quite large over years. On ultrasound, they often have a distinctive layered appearance, with internal daughter cysts or a detached membrane floating inside.
Hydatid cysts are a negligible concern in most of North America and Western Europe but remain common in pastoral regions of the Middle East, Central Asia, South America, and parts of Africa. If you have traveled to or lived in those areas and a cyst is found on your liver, the possibility of echinococcosis is worth raising with your doctor. Treatment can involve medication, percutaneous drainage under imaging guidance, or surgery, depending on the cyst’s stage and size.
Primary Liver Cancers
The fear behind any liver spot is, of course, cancer. Two primary cancers originate in the liver itself. Hepatocellular carcinoma (HCC) is far and away the more common of the two. It develops overwhelmingly in livers that are already diseased, typically by chronic hepatitis B, chronic hepatitis C, or cirrhosis from long-standing alcohol use or fatty liver disease. A healthy liver developing HCC out of the blue is exceedingly rare. HCC has a characteristic appearance on contrast-enhanced imaging: the tumor lights up brightly in the arterial phase (when contrast first floods in through the hepatic artery) and then “washes out” and becomes darker than surrounding liver in later phases.12PubMed. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid® That combination is so specific that HCC can often be diagnosed by imaging alone, without a biopsy, in people who already have known liver disease.
For small or atypical lesions where imaging is inconclusive, serum tumor markers and biopsy become important. Alpha-fetoprotein (AFP) remains the most widely used blood test for HCC, though it is not perfect; some HCCs produce little AFP, and some non-cancerous conditions can elevate it.13PubMed. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy For this reason, imaging and blood tests are used together, not in isolation.
Intrahepatic cholangiocarcinoma (ICC), a cancer of the bile ducts within the liver, is the second most common primary liver malignancy, though it is far less frequent than HCC. ICC accounts for about 10% of all bile duct cancers and tends to be diagnosed late because it often does not cause symptoms until it is advanced. Only about 15% of patients have disease that can be surgically removed at the time of diagnosis, and even with surgery the median survival is under three years.14PubMed Central. Intrahepatic cholangiocarcinoma: current perspectives
Metastases From Cancers Elsewhere
The liver is one of the most common destinations for cancer that has spread from another organ.15PubMed Central. Identifying primary tumor site of origin for liver metastases via a combination of handcrafted and deep learning features In fact, metastatic liver disease is more common than primary liver cancer in many populations. The liver’s dual blood supply, receiving blood from both the hepatic artery and the portal vein (which drains the entire gastrointestinal tract), makes it a natural landing zone for circulating cancer cells.
Which cancers spread to the liver depends partly on the patient’s age and sex. In younger women, breast cancer is the most common primary source of liver metastases, while colorectal cancer dominates in younger men. In older patients, the picture broadens to include lung, pancreatic, esophageal, stomach, and bladder cancers, among others.16PubMed. Epidemiology of liver metastases Liver metastases typically appear as multiple spots scattered through both lobes, though they can occasionally present as a solitary lesion. When a new liver lesion is found in someone with a known cancer history, the working assumption is metastatic disease until proven otherwise.
Sarcoidosis and Other Granulomatous Diseases
Sarcoidosis, an inflammatory condition that causes clusters of immune cells called granulomas to form in various organs, can involve the liver. When it does, imaging may show multiple small, dark nodules scattered throughout the liver tissue. These nodules can look disturbingly similar to liver metastases on ultrasound or CT, which sometimes triggers a cancer workup before the correct diagnosis is reached.17PubMed Central. Hepatic Sarcoidosis Other granulomatous infections, including tuberculosis and some fungal diseases, can produce a similar pattern.
The lesson from sarcoidosis is that not all multiple liver nodules mean cancer has spread. In a patient with known sarcoidosis or risk factors for granulomatous disease, the clinical context shifts the interpretation of imaging dramatically. Biopsy showing non-caseating granulomas can confirm the diagnosis and spare the patient from being treated as though they have metastatic cancer.
Peliosis Hepatis and Other Rare Vascular Conditions
Peliosis hepatis is an uncommon condition in which blood-filled cavities develop within the liver. These cavities can range from tiny to several centimeters and, on imaging, can mimic several different types of focal liver lesions, both benign and malignant.18PubMed. Peliosis hepatis: spectrum of imaging findings Peliosis has been linked to certain medications (including anabolic steroids and some immunosuppressants), chronic infections such as HIV and tuberculosis, and occasionally blood cancers. In some cases, no underlying cause is identified. Because the imaging appearance is variable and non-specific, peliosis is often diagnosed only after biopsy or when the clinical picture fits.
How Liver Spots Are Found and Worked Up
Most liver spots are incidental findings, discovered on an abdominal CT or ultrasound ordered for something unrelated. The first question a radiologist asks is whether the lesion has imaging characteristics that are clearly benign (a simple cyst, a classic hemangioma) or whether further workup is needed. Multiphasic contrast-enhanced CT and MRI are the standard tools for characterizing focal liver lesions when the initial finding is ambiguous.19PubMed Central. Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis MRI with hepatobiliary contrast agents can be especially helpful because these agents are taken up by normal liver cells, which means lesions that lack functioning liver cells (like metastases) stand out sharply on delayed images.
The patient’s clinical context matters enormously. A single small, well-defined spot in an otherwise healthy 30-year-old with no liver disease is overwhelmingly likely to be benign. The same spot in a 60-year-old with cirrhosis and hepatitis C is treated with far more urgency. Guidelines from organizations like the American College of Radiology provide structured recommendations for when to follow up and when to leave an incidental finding alone. Implementing these guidelines consistently has been a challenge: one quality improvement study found that even with a dedicated workflow and nurse coordinator, only about a third of patients who needed prompt MRI follow-up received it within 30 days.20PubMed. Implementation of Incidental Liver Lesion Clinically Integrated Workflow Increases Compliance With ACR Follow-Up Guidelines, Closing Care Gaps That gap matters because delayed follow-up can mean delayed diagnosis for the minority of lesions that turn out to be malignant.
Liver Spots in Children
The spectrum of liver lesions in children looks different from adults. The most common benign liver tumor in infants is infantile hepatic hemangioendothelioma, a vascular tumor that usually presents in the first six months of life. The most common malignant liver tumor in children is hepatoblastoma, which also tends to appear in very young children.21PubMed Central. Infantile hepatic hemangioendothelioma in comparison with hepatoblastoma in children: clinical and ultrasound features Both can present as a palpable abdominal mass or be detected on imaging. Distinguishing between them is critical because their management is completely different: hemangioendotheliomas often resolve on their own or respond to medical therapy, while hepatoblastoma requires chemotherapy and frequently surgery.
Older children and adolescents can develop some of the same lesions seen in adults, including FNH and, rarely, hepatocellular adenomas or HCC. But the baseline frequencies are different, and the diagnostic approach is adjusted accordingly. A liver spot in a child warrants evaluation at a center experienced in pediatric liver disease.
Imaging Artifacts That Create False Spots
Sometimes what looks like a spot on the liver is not a lesion at all but an artifact of how the scan was performed. One well-documented example is the transient hepatic attenuation difference, or THAD, a bright area that appears on CT during the arterial phase of contrast injection. THADs represent temporary alterations in blood flow through a segment of the liver, not actual masses. They are common after liver trauma, found in over half of follow-up CT scans in one study, and can complicate image interpretation by obscuring or mimicking true vascular injuries.22Diagnostics. The Impact of Transient Hepatic Attenuation Differences in the Diagnosis of Pseudoaneurysm and Arteriovenous Fistula on Follow-Up CT Scans after Blunt Liver Trauma THADs also occur in the absence of trauma and can be seen in patients with portal vein thrombosis, liver tumors that alter local blood flow, or even as a normal variant.
Recognizing THADs and other flow-related artifacts is part of a radiologist’s everyday work, but it underscores an important point for patients: not every bright or dark area on a liver scan represents a physical structure sitting in your liver. If a radiologist recommends a follow-up scan to see whether a finding persists, it may be precisely because the initial appearance could be an artifact that disappears on repeat imaging or on a different type of scan.